Lleo A. SVR is the strongest predictor of occurrence and recurrence of hepatocellular carcinoma in HCV cirrhotic patients after treatment with DAAs: A prospective multi-centric Italian study. PS-154.
Vebicorvir plus NRTI bij virologisch onderdrukte patiënten met chronische HBV
nov 2022 | Hepatitis, Hepatologie